You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Bulk Pharmaceutical API Sources for SODIUM CHLORIDE 3% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for SODIUM CHLORIDE 3% IN PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 204439_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 310166_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 378860_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 433209_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 450006_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Sodium Chloride 3% in Plastic Container

Last updated: August 14, 2025

Introduction

Sodium chloride 3% solutions are widely used in medical settings for various indications, including wound irrigation, fluid replacement, and laboratory testing. The consistent quality, purity, and supply chain reliability of the Active Pharmaceutical Ingredient (API) are crucial for pharmaceutical manufacturers and healthcare providers. This article provides a comprehensive analysis of global sources of bulk sodium chloride API suitable for pharmaceutical-grade production, focusing on the key suppliers, regions, regulatory status, and quality considerations.

Overview of Sodium Chloride API

Sodium chloride (NaCl), commonly known as table salt, is a chemically simple compound with extensive industrial and medical applications. Pharmaceutical-grade sodium chloride must adhere to rigorous standards, such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), or equivalent, ensuring purity, microbiological safety, and compatibility with medical use.

For injectable or sterile solutions like 3% sodium chloride, the API must be produced under strict Good Manufacturing Practices (GMP), with appropriate sterilization, endotoxin control, and validation processes.

Major Global Sources of Sodium Chloride API

1. India

India remains a dominant supplier of pharmaceutical-grade sodium chloride globally, owing to its large-scale production facilities and competitive pricing. Several Indian API manufacturers are recognized by the regulatory authorities and supply to international markets.

  • Significant Manufacturers:

    • Shivaji Enterprises: Has GMP-certified facilities for producing pharmaceutical-grade sodium chloride, supplying to Asia, Europe, and North America.
    • S.H. Industry: Noted for producing sterile saline sodium chloride for injectable use, with certifications compliant with US and EU standards.
    • Volan Labs: A GMP-certified manufacturer specializing in sterile and non-sterile sodium chloride powders.
  • Regulatory Compliance: Many Indian manufacturers have obtained US FDA, EU EMA, and UK MHRA approvals, facilitating exports to regulated markets.

  • Supply Chain Advantages: Cost-effective manufacturing, high production capacity, and a robust export network.

2. China

China is another leading source of pharmaceutical sodium chloride, known for large-scale manufacturing facilities and competitive pricing.

  • Major Suppliers:

    • Hubei Yuancheng Pharmaceutical Co., Ltd.: Offers pharmaceutical-grade sterile and non-sterile sodium chloride, complying with USP and EP standards.
    • Lvyuan Pharmaceutical: Provides GMP-compliant sodium chloride APIs suitable for injection and infusion solutions.
    • Yiling Pharmaceutical: Also supplies pharmaceutical-grade salts including sodium chloride, with robust export channels.
  • Quality and Certification: Most Chinese suppliers have attained ISO, GMP, and where applicable, US FDA registration, ensuring quality assurance for international markets.

3. Europe

European companies focus on high-quality, highly purified APIs with strict adherence to pharmacopoeial standards. They typically serve clients requiring stringent compliance with EMA regulations.

  • Leading European API Suppliers:

    • CordenPharma (Germany): Offers pharmaceutical-grade sodium chloride, including sterile APIs, with extensive GMP certification.
    • Bleckmann & Co. GmbH (Germany): Supplies high-purity sodium chloride APIs for sterile and non-sterile applications.
    • Euroapi (France): Provides various inorganic salts, including pharmaceutical-grade sodium chloride, with emphasis on compliance and quality.
  • Strengths: High purity standards, reliable supply chains, and regulatory support for complex formulations.

4. United States

U.S.-based manufacturers primarily supply sodium chloride APIs adhering to USP standards, with a focus on sterile, injectable grades.

  • Key Suppliers:

    • BASF Corporation: Produces pharmaceutical-grade sodium chloride formulations, with extensive GMP compliance.
    • Fresenius Kabi: Offers bulk sodium chloride suitable for IV solutions, ensuring strict adherence to regulatory standards.
  • Regulatory Framework: Well-established quality systems aligned with FDA regulations facilitate seamless integration into U.S.-based pharmaceutical manufacturing.

5. Latin America and Other Regions

Manufacturers in Latin America, such as Argentina and Brazil, are emerging sources of pharmaceutical-grade sodium chloride, supporting regional markets with competitive pricing and quality.

Quality and Regulatory Considerations

When sourcing sodium chloride API for pharmaceutical use, several factors are paramount:

  • Purity Specifications: Must meet pharmacopoeial monographs, typically USP <631> or EP specifications, including limits on heavy metals, endotoxins, microbial contamination, and residual solvents.

  • Manufacturing Practices: GMP certification is essential to ensure consistency, safety, and quality.

  • Sterility and Endotoxins: For injectable applications, APIs must be sterile and free from pyrogens; suppliers providing sterile, pre-sterilized APIs streamline manufacturing processes.

  • Regulatory Acceptance: Compatibility with regulatory authorities (FDA, EMA, PMDA, etc.) facilitates global distribution.

Supply Chain Dynamics

The global supply chain for sodium chloride API is characterized by:

  • Price Competition: Indian and Chinese manufacturers offer cost-effective options.
  • Lead Times: European and U.S. suppliers, often with more stringent quality assurance processes, may have longer lead times but provide higher confidence in regulatory compliance.
  • Geopolitical Factors: Trade policies, tariffs, and export restrictions can influence sourcing decisions.

Emerging Trends and Challenges

  • Quality Assurance: Increasing regulatory scrutiny emphasizes rigorous testing and documentation.
  • Sustainability: Environmental considerations are influencing production practices, especially in major manufacturing regions.
  • Supply Security: Diversification strategies are vital to mitigating risks associated with geopolitical disruptions or supply shortages.

Conclusion

Selecting a reliable bulk API source for sodium chloride 3% solutions in plastic containers hinges on balancing quality, regulatory compliance, cost, and supply chain stability. Indian and Chinese manufacturers dominate the global supply, offering competitive prices and certified quality. European and U.S. suppliers excel in providing high-purity, regulatory-approved APIs suitable for sensitive applications requiring specialized standards.

Manufacturers and healthcare providers must evaluate suppliers based on certifications, batch consistency, regulatory alignment, and logistical capacities to ensure continuous, compliant, and safe supply of sodium chloride API for medical formulations.


Key Takeaways

  • India and China are the primary global sources of pharmaceutical-grade sodium chloride API, offering competitive pricing and broad regulatory approvals.
  • European and U.S. suppliers emphasize high purity and stringent quality compliance, ideal for highly regulated markets.
  • Regulatory compliance, including GMP certification, endotoxin limits, and sterility, is critical for APIs intended for injectable applications.
  • Sourcing decisions should consider supply chain robustness, lead times, and geopolitical factors.
  • Diversifying suppliers across regions mitigates risks related to shortages or regulatory changes.

FAQs

1. What are the critical quality standards for pharmaceutical sodium chloride API?
Pharmaceutical sodium chloride must meet USP or EP specifications, including limits on heavy metals, bacterial endotoxins, microbial contamination, and residual solvents. Sterile APIs must be produced under GMP and validated sterilization processes.

2. Which regions are the most reliable for sourcing sodium chloride API?
India and China are primary suppliers, with strong manufacturing capacities and regulatory approvals. Europe and the U.S. provide high-quality APIs, especially for highly regulated markets, with stringent compliance standards.

3. How do regulatory approvals influence API sourcing?
Regulatory approvals, such as FDA, EMA, or MHRA, ensure that the API meets safety, efficacy, and quality standards, facilitating international distribution and reducing regulatory hurdles.

4. Is it feasible to source non-sterile sodium chloride for injectable solutions?
No. For injectable 3% sodium chloride solutions, the API must be sterile, endotoxin-free, and produced under GMP in sterile conditions, limiting sourcing to specialized manufacturers.

5. What are current challenges in the sodium chloride API supply chain?
Challenges include quality assurance, geopolitical tensions affecting trade, supply chain disruptions, and increasing regulatory scrutiny, all necessitating strategic supplier diversification and vigilant quality management.


References:

  1. United States Pharmacopeia. USP General Chapter <631>, Inorganic Chemical Tests.
  2. European Pharmacopoeia. Sodium Chloride monograph.
  3. Industry reports on pharmaceutical API manufacturing and supply chain.
  4. Company websites and certification disclosures of leading API manufacturers.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.